Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 0.4171
-7.06 %
$ 12.5 M
Market Cap
-0.27
P/E
PRPH - TOTAL ASSETS
Total Assets PRPH - ProPhase Labs, Inc.
91.9 M
LAST VALUE
1.46%
2 YEAR CAGR
34.69%
5 YEAR CAGR
18.10%
10 YEAR CAGR